2022
DOI: 10.1002/hed.27250
|View full text |Cite
|
Sign up to set email alerts
|

Predictive effect of pretreatment nutritional risk and GLIM‐defined malnutrition on the nutrition impact symptom clusters in patients with head and neck cancer undergoing radiotherapy

Abstract: Background Evidence supporting predictive effects of pretreatment nutritional risk and nutritional status on nutrition impact symptom (NIS) clusters during radiotherapy in patients with head and neck cancer (HNC) is insufficient. Methods At baseline (T1), we collected severity and interference of NIS (Head and Neck Patient Symptom Checklist), nutritional risk, and nutritional status. During (T2) and at the end of radiotherapy (T3), we re‐evaluated NIS. Symptom clusters were identified by exploratory factor ana… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…Many cases of cancer could be prevented by adopting a healthful lifestyle which includes a healthy dietary pattern [1][2][3]. While historically there have been insufficient effective treatments such as radiotherapy, chemotherapy, or local therapies in oncology patients, the therapy paradigm has been revolutionised in the last decade by the introduction of systemic therapies and lately with next-generation targeted therapies [4,5].…”
Section: Health Backgroundmentioning
confidence: 99%
“…Many cases of cancer could be prevented by adopting a healthful lifestyle which includes a healthy dietary pattern [1][2][3]. While historically there have been insufficient effective treatments such as radiotherapy, chemotherapy, or local therapies in oncology patients, the therapy paradigm has been revolutionised in the last decade by the introduction of systemic therapies and lately with next-generation targeted therapies [4,5].…”
Section: Health Backgroundmentioning
confidence: 99%